| scholarly article | Q13442814 |
| P2093 | author name string | Yong Li | |
| Wei Wu | |||
| Xianwei Wang | |||
| Fengzhu Li | |||
| Changting Shan | |||
| P2860 | cites work | MCM2--a promising marker for premalignant lesions of the lung: a cohort study | Q21261331 |
| Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance. | Q48744502 | ||
| Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a. | Q50910382 | ||
| Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. | Q51459307 | ||
| Potential role of minichromosome maintenance protein 2 as a screening biomarker in esophageal cancer high-risk population in China. | Q53275133 | ||
| MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker. | Q53307455 | ||
| Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma. | Q53613408 | ||
| Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas. | Q53639618 | ||
| MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. | Q53677297 | ||
| A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma | Q73887387 | ||
| Expression of TGFbeta type-II receptor in association with markers of proliferation and apoptosis in premalignant lung lesions | Q80739027 | ||
| Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma | Q81621762 | ||
| [Expression of minichromosome maintenance protein 2 in colonic adenocarcinoma, adenoma and normal colonic mucosa and its clinical significance] | Q82001074 | ||
| The Mcm2-7 replicative helicase: a promising chemotherapeutic target | Q26861045 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis | Q33688672 | ||
| Mutants of S. cerevisiae defective in the maintenance of minichromosomes. | Q34014296 | ||
| miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis | Q34023389 | ||
| MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2 | Q34104063 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value | Q35709269 | ||
| Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system | Q36055579 | ||
| Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade | Q36609412 | ||
| Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications | Q36611370 | ||
| Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imaging analysis-based study of 428 cases | Q37023800 | ||
| Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis | Q38072983 | ||
| Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion. | Q38342145 | ||
| Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer. | Q38408657 | ||
| Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. | Q38457075 | ||
| Chromosomal aberrations and gene expression profiles in non-small cell lung cancer | Q38516868 | ||
| How and why multiple MCMs are loaded at origins of DNA replication | Q38833501 | ||
| MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas | Q38903793 | ||
| MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation | Q39022633 | ||
| Translating cancer epigenomics into the clinic: focus on lung cancer | Q39394558 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer | Q40362934 | ||
| MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications | Q40533584 | ||
| Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer | Q42360040 | ||
| MCM2-regulated functional networks in lung cancer by multi-dimensional proteomic approach | Q42378823 | ||
| Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67. | Q42435966 | ||
| Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. | Q45964481 | ||
| Expression profile reveals novel prognostic biomarkers in hepatocellular carcinoma. | Q45996187 | ||
| Current Landscape of Targeted Therapy in Lung Cancer. | Q46034707 | ||
| Prognostic significance of CD133 and ezrin expression in colorectal carcinoma. | Q46403034 | ||
| MCMs expression in lung cancer: implication of prognostic significance | Q47157785 | ||
| Expression of minichromosome maintenance genes in renal cell carcinoma | Q47159187 | ||
| Cancer statistics, 2018. | Q47191906 | ||
| Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitors | Q47351169 | ||
| DNA Replication Licensing Proteins for Early Detection of Lung Cancer | Q47367908 | ||
| New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer | Q47647930 | ||
| miR-448 is a novel prognostic factor of lung squamous cell carcinoma and regulates cells growth and metastasis by targeting DCLK1. | Q47944968 | ||
| Clinical applications of textural analysis in non-small cell lung cancer. | Q47966288 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | squamous cell carcinoma | Q681817 |
| P304 | page(s) | 5025-5034 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | OncoTargets and Therapy | Q7092081 |
| P1476 | title | Minichromosome maintenance protein 2 correlates with the malignant status and regulates proliferation and cell cycle in lung squamous cell carcinoma | |
| P478 | volume | 11 |
| Q93009232 | Identifying critical state of complex diseases by single-sample Kullback-Leibler divergence |
| Q90079432 | Involvement of Dual Strands of miR-143 (miR-143-5p and miR-143-3p) and Their Target Oncogenes in the Molecular Pathogenesis of Lung Adenocarcinoma |
| Q89849492 | MCMs in Cancer: Prognostic Potential and Mechanisms |
| Q64059499 | Prognostic relevance of topoisomerase II α and minichromosome maintenance protein 6 expression in colorectal cancer |
| Q90216681 | Prognostic significance of minichromosome maintenance mRNA expression in human lung adenocarcinoma |
| Q64109884 | Regulation of by Antitumor Inhibits Cancer Cell Aggressiveness Features in Lung Squamous Cell Carcinoma |
Search more.